Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients’ Survival: A Randomized Controlled Trial

  • Nesreen M. Sabry
  • , Tamer M. Naguib
  • , Ahmed M. Kabel
  • , El Sayed Khafagy
  • , Hany H. Arab
  • , Walid A. Almorsy

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients’ Survival: A Randomized Controlled Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science